Knowles Corp

Price is entrenched in a Stage 4 decline with confirmed lower highs and lower lows since late June, trading below the declining 9EMA, 20EMA, and 50DMA with rallies repeatedly rejected by dynamic resistance. Active bearish patterns (Support Failure, Bearish Pivot Point) reinforce ongoing structural breakdown, and despite an oversold RSI, there is no evidence of exhaustion or reversal structure. The long-term uptrend above the 200DMA remains intact but secondary to the prevailing medium-term downtrend, supporting a Sell Now posture.

• ↑Q1 revenue $153M (+16% YoY) backlog underpins growth
• ↑Q1 EPS $0.27 (+50% YoY) shows profit momentum
• ↓Management forecasts MedTech growth at 2–4%, below peers